Clinical and genetic aspects of alopecia areata: a cutting edge review

CY Ho, CY Wu, JYF Chen, CY Wu - Genes, 2023 - mdpi.com
Alopecia areata (AA) is a chronic, non-scarring, immune-mediated skin disease that affects
approximately 0.5–2% of the global population. The etiology of AA is complex and involves …

Novel investigational drugs for alopecia areata and future perspectives

I Chim, R Ghiya, RD Sinclair… - Expert Opinion on …, 2024 - Taylor & Francis
Introduction Alopecia areata (AA) is an immune-mediated disease that causes non-scarring
hair loss. While acute, solitary patches often spontaneously remit, developing secondary …

Enhancing Quality of Life and Sexual Functioning in Female Androgenetic Alopecia: Therapeutic Potential of Hair Follicle-Derived Stem Cells

K Krefft-Trzciniecka, H Cisoń, A Pakiet, D Nowicka… - Healthcare, 2024 - mdpi.com
Background: The study aimed to examine the impact of stem cell treatment on quality of life
(QoL) and sexual functioning in women with androgenetic alopecia (AGA). Methods: Twenty …

Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations

A Courtney, JC Su - Cosmetics, 2024 - mdpi.com
Alopecia areata (AA) presents a challenging and unpredictable condition associated with
substantial psychosocial and financial burdens. A chronic, relapsing form of non-scarring …

A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System

CJ Song, CA Riley, BD Wilkison, S Cho - Military medicine, 2024 - academic.oup.com
Introduction Alopecia areata (AA) is a disease that manifests as patchy hair loss on the scalp
and other parts of the body; severe disease may result in disfigurement, functional …

Patient-Reported Burden of Severe Alopecia Areata: First Results from the Multinational Alopecia Areata Unmet Need Survey

A Bewley, I Figueras-Nart, J Zhang… - Clinical, Cosmetic …, 2024 - Taylor & Francis
Purpose Alopecia areata (AA) is an autoimmune disease characterized by hair loss that has
significant psychosocial implications. This study aims to describe the patient-reported …

[HTML][HTML] Real-world experience quantifying access to JAK inhibitor care for alopecia areata patients: a patient-centered survey study

A Nohria, D Desai, A Lee, L Anderson… - … Journal of Women's …, 2024 - journals.lww.com
Background: Janus kinase inhibitor (JAKi) therapy has revolutionized the treatment
landscape for alopecia areata (AA); however, access may be limited by a lack of insurance …

[HTML][HTML] Insights into Alopecia Areata: A Systematic Review of Prevalence, Pathogenesis, and Psychological Consequences

E Bahashwan, M Alshehri - The Open …, 2024 - opendermatologyjournal.com
Background Alopecia areata is an autoimmune condition distinguished by visual non-
scarring hair loss in different head and face regions. The condition affects every age group …

[PDF][PDF] КЛІНІКО-ПАТОГЕНЕТИЧНЕ ОБҐРУНТУВАННЯ ЛІКУВАННЯ ХВОРИХ НА ГНІЗДОВУ АЛОПЕЦІЮ, АСОЦІЙОВАНУ З МЕТАБОЛІЧНИМ СИНДРОМОМ

ІІ ГОРДА - 2023 - ir.nuozu.edu.ua
Дисертація на здобуття ступеня доктора філософії з галузі знань 22–«Охорона
здоров'я» за спеціальністю 222–«Медицина».–Національний університет охорони …

Клінічні рекомендації від укпаїнського товариства дослідження волосся. діагностика та лікування гніздової алопеції

І Сербіна, Х Кузьма, Т Лядова, О Літус… - Актуальні …, 2023 - periodicals.karazin.ua
Гніздова алопеція–імуноопосередковане захворювання, обумовлене взаємодією
генетичних факторів та екзогенних тригерів, що призводить до активації сигнального …